D.E. Shaw & Co’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-37,400
| Closed | -$4.93M | – | 4112 |
|
|
2018
Q4 | $4.93M | Sell |
37,400
-18,400
| -33% | -$2.36M | 0.01% | 1523 |
|
|
2018
Q3 | $7.46M | Buy |
55,800
+40,800
| +272% | +$6.11M | 0.01% | 1292 |
|
|
2018
Q2 | $2.39M | Buy |
+15,000
| New | +$2.22M | ﹤0.01% | 2102 |
|
|
2016
Q2 | – | Sell |
-20,000
| Closed | -$2.78M | – | 3636 |
|
|
2016
Q1 | $2.78M | Buy |
20,000
+16,700
| +506% | +$2.29M | 0.01% | 1653 |
|
|
2015
Q4 | $531K | Hold |
3,300
| – | – | ﹤0.01% | 3057 |
|
|
2015
Q3 | $440K | Hold |
3,300
| – | – | ﹤0.01% | 3139 |
|
|
2015
Q2 | $378K | Sell |
3,300
-8,700
| -73% | -$1.04M | ﹤0.01% | 3311 |
|
|
2015
Q1 | $1.43M | Sell |
12,000
-33,600
| -74% | -$4.48M | ﹤0.01% | 2272 |
|
|
2014
Q4 | $6.64M | Buy |
45,600
+5,300
| +13% | +$666K | 0.01% | 1365 |
|
|
2014
Q3 | $5.31M | Sell |
40,300
-54,300
| -57% | -$7.15M | 0.01% | 1528 |
|
|
2014
Q2 | $11.8M | Buy |
94,600
+9,700
| +11% | +$1.25M | 0.02% | 990 |
|
|
2014
Q1 | $13.6M | Buy |
84,900
+47,800
| +129% | +$7.87M | 0.02% | 864 |
|
|
2013
Q4 | $4.99M | Buy |
37,100
+5,900
| +19% | +$758K | 0.01% | 1674 |
|
|
2013
Q3 | $3.39M | Buy |
31,200
+27,100
| +661% | +$2.93M | 0.01% | 1956 |
|
|
2013
Q2 | $347K | Buy |
+4,100
| New | +$367K | ﹤0.01% | 3486 |
|
D.E. Shaw & Co's ATHN Position: Q1 2019 in Review
D.E. Shaw & Co sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 67,636 shares — an estimated $8.92M sold.
D.E. Shaw & Co first reported a position in ATHN in Q2 2013 and held it in 13 quarters. The position peaked at $21.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- D.E. Shaw & Co reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- D.E. Shaw & Co sold 67,636 Athenahealth, Inc. shares in Q1 2019, an estimated $8.92M.
- D.E. Shaw & Co first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 13 quarters.
- D.E. Shaw & Co's Athenahealth, Inc. position peaked at $21.8M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.